---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-016935"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2022-12-23T23:59:59+00:00"
generated_at: "2026-06-20T23:23:42.143906+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences CCO Renaud Maloberti resigns effective Jan 13, 2023

## Summary
- Renaud Maloberti resigned as Chief Commercial Officer, effective January 13, 2023.
- Resignation not related to any disagreement with company's operations, policies, or practices.
- No replacement for the CCO position announced.

## SEC filing metadata
- accession: 0001654954-22-016935
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2022-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016935/0001654954-22-016935-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016935/ndra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-016935
- JSON: https://secwatch.observer/filing/0001654954-22-016935.json
- Plain text: https://secwatch.observer/filing/0001654954-22-016935.txt

## Key facts
- Executive change
  Renaud Maloberti resigned as Chief Commercial Officer at ENDRA Life Sciences Inc..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On December 21, 2022, Renaud Maloberti notified ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) of his resignation as the Company’s Chief Commercial Officer, effective January 13, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681682/000165495422016935/0001654954-22-016935-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.